| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |